Report Detail
Global Metabolic Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM3215875 |
- 30 March, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.
According to this study, over the next five years the Metabolic Disorder Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Metabolic Disorder Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Metabolic Disorder Therapeutics market by product type, application, key companies and key regions.
This study considers the Metabolic Disorder Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Lysosomal Storage Diseases
Diabetes
Inherited Metabolic Disorders
Hypercholesterolemia
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Oral
Parenteral
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk A/S
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck KgaA
Amgen, Inc.
AstraZeneca PLC
Actelion Pharmaceuticals Ltd.
Shire PLC
AbbVie, Inc.
Biocon Ltd.
BioMarin Pharmaceutical, Inc.
Bristol-Myers Squibb Company
Cipla, Inc.
CymaBay Therapeutics, Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Metabolic Disorder Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Metabolic Disorder Therapeutics market by identifying its various subsegments.
Focuses on the key global Metabolic Disorder Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Metabolic Disorder Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Metabolic Disorder Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Metabolic Disorder Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Metabolic Disorder Therapeutics Market Size 2014-2024
- 2.1.2 Metabolic Disorder Therapeutics Market Size CAGR by Region
- 2.2 Metabolic Disorder Therapeutics Segment by Type
- 2.2.1 Lysosomal Storage Diseases
- 2.2.2 Diabetes
- 2.2.3 Obesity
- 2.2.4 Inherited Metabolic Disorders
- 2.2.5 Hypercholesterolemia
- 2.3 Metabolic Disorder Therapeutics Market Size by Type
- 2.3.1 Global Metabolic Disorder Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 Metabolic Disorder Therapeutics Segment by Application
- 2.4.1 Oral
- 2.4.2 Parenteral
- 2.4.3 Others
- 2.5 Metabolic Disorder Therapeutics Market Size by Application
- 2.5.1 Global Metabolic Disorder Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global Metabolic Disorder Therapeutics by Players
- 3.1 Global Metabolic Disorder Therapeutics Market Size Market Share by Players
- 3.1.1 Global Metabolic Disorder Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global Metabolic Disorder Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global Metabolic Disorder Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Metabolic Disorder Therapeutics by Regions
- 4.1 Metabolic Disorder Therapeutics Market Size by Regions
- 4.2 Americas Metabolic Disorder Therapeutics Market Size Growth
- 4.3 APAC Metabolic Disorder Therapeutics Market Size Growth
- 4.4 Europe Metabolic Disorder Therapeutics Market Size Growth
- 4.5 Middle East & Africa Metabolic Disorder Therapeutics Market Size Growth
5 Americas
- 5.1 Americas Metabolic Disorder Therapeutics Market Size by Countries
- 5.2 Americas Metabolic Disorder Therapeutics Market Size by Type
- 5.3 Americas Metabolic Disorder Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Metabolic Disorder Therapeutics Market Size by Countries
- 6.2 APAC Metabolic Disorder Therapeutics Market Size by Type
- 6.3 APAC Metabolic Disorder Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Metabolic Disorder Therapeutics by Countries
- 7.2 Europe Metabolic Disorder Therapeutics Market Size by Type
- 7.3 Europe Metabolic Disorder Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Metabolic Disorder Therapeutics by Countries
- 8.2 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Type
- 8.3 Middle East & Africa Metabolic Disorder Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Metabolic Disorder Therapeutics Market Forecast
- 10.1 Global Metabolic Disorder Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global Metabolic Disorder Therapeutics Forecast by Regions
- 10.2.1 Global Metabolic Disorder Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Metabolic Disorder Therapeutics Forecast by Type
- 10.8 Global Metabolic Disorder Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 Novo Nordisk A/S
- 11.1.1 Company Details
- 11.1.2 Metabolic Disorder Therapeutics Product Offered
- 11.1.3 Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Novo Nordisk A/S News
- 11.2 Sanofi S.A.
- 11.2.1 Company Details
- 11.2.2 Metabolic Disorder Therapeutics Product Offered
- 11.2.3 Sanofi S.A. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Sanofi S.A. News
- 11.3 Boehringer Ingelheim GmbH
- 11.3.1 Company Details
- 11.3.2 Metabolic Disorder Therapeutics Product Offered
- 11.3.3 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Boehringer Ingelheim GmbH News
- 11.4 Eli Lilly and Company
- 11.4.1 Company Details
- 11.4.2 Metabolic Disorder Therapeutics Product Offered
- 11.4.3 Eli Lilly and Company Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Eli Lilly and Company News
- 11.5 Merck KgaA
- 11.5.1 Company Details
- 11.5.2 Metabolic Disorder Therapeutics Product Offered
- 11.5.3 Merck KgaA Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Merck KgaA News
- 11.6 Amgen, Inc.
- 11.6.1 Company Details
- 11.6.2 Metabolic Disorder Therapeutics Product Offered
- 11.6.3 Amgen, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Amgen, Inc. News
- 11.7 AstraZeneca PLC
- 11.7.1 Company Details
- 11.7.2 Metabolic Disorder Therapeutics Product Offered
- 11.7.3 AstraZeneca PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 AstraZeneca PLC News
- 11.8 Actelion Pharmaceuticals Ltd.
- 11.8.1 Company Details
- 11.8.2 Metabolic Disorder Therapeutics Product Offered
- 11.8.3 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Actelion Pharmaceuticals Ltd. News
- 11.9 Shire PLC
- 11.9.1 Company Details
- 11.9.2 Metabolic Disorder Therapeutics Product Offered
- 11.9.3 Shire PLC Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Shire PLC News
- 11.10 AbbVie, Inc.
- 11.10.1 Company Details
- 11.10.2 Metabolic Disorder Therapeutics Product Offered
- 11.10.3 AbbVie, Inc. Metabolic Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 AbbVie, Inc. News
- 11.11 Biocon Ltd.
- 11.12 BioMarin Pharmaceutical, Inc.
- 11.13 Bristol-Myers Squibb Company
- 11.14 Cipla, Inc.
- 11.15 CymaBay Therapeutics, Inc.
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Metabolic Disorder Therapeutics . Industry analysis & Market Report on Metabolic Disorder Therapeutics is a syndicated market report, published as Global Metabolic Disorder Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Metabolic Disorder Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
